Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
A very fast-paced company that has a lot of turning around to do under new leadership. I am eager and excited to see what the new CEO does and hope to see Karyopharm go from being a fledgling company to a well-established, competitive company.
Quelles sont les meilleures choses à propos de votre équipe?
I get to work cross-functionally with a variety of talented, funny, hardworking people.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
There are certain teams that are trying really hard to improve on the company culture and they are bright spots in my day. Work wouldn't be the same without them.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
There are certain members of the leadership team that are incredibly forward-thinking and are trying to improve on Karyopharm culture as a whole. I think they're doing a fabulous job and hope they keep at it!
Qu’est-ce qui vous rend le plus heureux au travail?
I have an incredible manager and consider myself very lucky to be able to learn from them at such a crucial stage in my career. I'm consistently impressed with their thoughtfulness, consideration, and well-rounded approach to management.
Other Employee Reviews for Karyopharm Therapeutics
×